DK3436047T3 - Duale Ace-C-Domain-inhibitorer - Google Patents
Duale Ace-C-Domain-inhibitorer Download PDFInfo
- Publication number
- DK3436047T3 DK3436047T3 DK17716015.7T DK17716015T DK3436047T3 DK 3436047 T3 DK3436047 T3 DK 3436047T3 DK 17716015 T DK17716015 T DK 17716015T DK 3436047 T3 DK3436047 T3 DK 3436047T3
- Authority
- DK
- Denmark
- Prior art keywords
- domain inhibitors
- dual ace
- ace
- dual
- inhibitors
- Prior art date
Links
- 230000009977 dual effect Effects 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201605602 | 2016-04-01 | ||
PCT/IB2017/051856 WO2017168383A1 (en) | 2016-04-01 | 2017-03-31 | Dual ace c-domain/nep inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3436047T3 true DK3436047T3 (da) | 2024-05-06 |
Family
ID=58489751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK17716015.7T DK3436047T3 (da) | 2016-04-01 | 2017-03-31 | Duale Ace-C-Domain-inhibitorer |
Country Status (5)
Country | Link |
---|---|
US (1) | US11129805B2 (da) |
EP (1) | EP3436047B1 (da) |
CA (1) | CA3019462A1 (da) |
DK (1) | DK3436047T3 (da) |
WO (1) | WO2017168383A1 (da) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL303494A (en) * | 2020-12-10 | 2023-08-01 | Baropace Inc | Treatment of drug-resistant hypertension and heart failure with ejection fraction preservation by combined treatment BAROPACING and beta blockers |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002087621A1 (en) * | 2001-04-30 | 2002-11-07 | Shire Laboratories Inc. | Pharmaceutical composition including ace/nep inhibitors and bioavailability enhancers |
-
2017
- 2017-03-31 US US16/090,311 patent/US11129805B2/en active Active
- 2017-03-31 CA CA3019462A patent/CA3019462A1/en active Pending
- 2017-03-31 EP EP17716015.7A patent/EP3436047B1/en active Active
- 2017-03-31 DK DK17716015.7T patent/DK3436047T3/da active
- 2017-03-31 WO PCT/IB2017/051856 patent/WO2017168383A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
CA3019462A1 (en) | 2017-10-05 |
US11129805B2 (en) | 2021-09-28 |
EP3436047A1 (en) | 2019-02-06 |
WO2017168383A1 (en) | 2017-10-05 |
EP3436047B1 (en) | 2024-04-24 |
US20190111014A1 (en) | 2019-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3442972T3 (da) | Bromdomænehæmmere | |
DK3283625T3 (da) | Nukleasemedieret genomeditering | |
DK3331869T3 (da) | Muscarinagonister | |
DK3305788T3 (da) | Janus-kinase-hæmmer | |
DK3277719T3 (da) | Polypeptider | |
DK3360890T3 (da) | Genterapi | |
DK3331528T3 (da) | Muskarinagonister | |
DK3571192T3 (da) | Jak1-selektive inhibitorer | |
DK3331529T3 (da) | Muskarinagonister | |
DK3310450T3 (da) | Olie-vand-separator | |
DK3186242T3 (da) | Alfa-amino-beta-carboxymuconsyre-semialdehyd-decarboxylasehæmmere | |
DK3630744T3 (da) | Pyrazol-magl-inhibitorer | |
MA43367A (fr) | Inhibiteurs de métallo-bêta-lactamases | |
DK3114120T3 (da) | Tetrazolon-substituerede dihydropyridinon-mgat2-hæmmere | |
DK3341379T3 (da) | EZH2-hæmmere | |
DK3270930T3 (da) | Præeklampsi | |
DK3394281T3 (da) | Gærcelle | |
MA46280A (fr) | Inhibiteurs de la dopamine-b-hydroxylase | |
DK3292136T3 (da) | Penicillin-g-acylaser | |
DE112015006486A5 (de) | Inkubationsrinne | |
DK3274482T3 (da) | Stenborsknop | |
MA44607A (fr) | Inhibiteurs de kinase | |
DK3318308T3 (da) | Badmintonketsjer | |
DE112015005906A5 (de) | Gurtschlossbringer | |
DK3481826T3 (da) | Tyrosinkinaseinhibitorer |